Starch-poly-є-caprolactone Microparticles Reduce the Needed Amount of BMP-2

BMP-2 is currently administered clinically using collagen matrices often requiring large amounts of BMP-2 due to burst release over a short period of time. We developed and tested a novel injectable drug delivery system consisting of starch-poly-є-caprolactone microparticles for inducing osteogenesi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Balmayor, E. R., Feichtinger, G. A., Azevedo, H. S., van Griensven, M., Reis, R. L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer-Verlag 2009
Gaiak:
Symposium: Tribute to Dr. Marshall Urist: Musculoskeletal Growth Factors
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2772940/
https://ncbi.nlm.nih.gov/pubmed/19557487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11999-009-0954-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak